相关实验视频

Updated: Sep 11, 2025

A Method to Assess Fc-mediated Effector Functions Induced by Influenza Hemagglutinin Specific Antibodies

A Method to Assess Fc-mediated Effector Functions Induced by Influenza Hemagglutinin Specific Antibodies

Published on: February 23, 2018

开发和外部验证FluScoreVax流感风险评分的发展和外部验证,该评分包含疫苗状态

Mark H Ebell¹, Yewen Chen², Fangzhi Luo²

¹From the Department of Family Medicine, College of Human Medicine, Michigan State University, East Lansing, MI, USA (MHE); Department of Epidemiology and Biostatistics, College of Public Health, University of Georgia, Athens, GA, USA (YC, FL, YS); Centre for General Practice, Department of Family Medicine & Population Health, University of Antwerp, Antwerp, Belgium, b. Vaccine & Infectious Disease Institute, University of Antwerp, Antwerp, Belgium (SC); Laboratory of Medical Microbiology, Vaccine & Infectious Disease Institute, University of Antwerp, Antwerp, Belgium (SC, MI); Primary Care and Population Sciences, University of Southampton, Southampton, UK (PL); Department of Family Medicine and Community Health, University of Wisconsin, Madison, WI USA (BB), Department of Family Medicine, Georgetown University, Washington, D.C., USA (DM). ebell.mark@gmail.com.

Journal of the American Board of Family Medicine : JABFM

|August 11, 2025

概括

一个新的风险评分,FluScoreVax,准确地识别了流感的低风险患者,只有7%的测试结果呈阳性. 这个工具有助于通过疫苗接种史和症状来诊断流感.

科学领域:

流行病学流行病学
传染性疾病传染性疾病
临床决策支持临床决策支持

背景情况:

准确的流感诊断对于适当的治疗和公共卫生管理至关重要.
现有的诊断方法可能是资源密集型或耗时的.
一个简单的,经过验证的风险评分可以帮助临床医生在门诊机构.

研究的目的:

开发和外部验证流感诊断的简单风险评分.
该得分包括疫苗接种史和患者报告的症状.
在不同的人群中评估分数的准确性和校准.

主要方法:

风险评分是使用从欧洲 (GRACE) 和美国 (EAST-PC) 门诊数据 (2007-2010) 的逻辑回归来得出的.
收集了患者报告的症状和疫苗接种情况.
通过聚合酶链反应 (PCR) 确认了流感的诊断.

主要成果:

开发了6项风险评分 (FluScoreVax),曲线下的面积 (AUC) 为0.75,用于导出和内部验证.
美国数据的外部验证显示了出色的校准.
该评分将61%的患者确定为低风险患者,只有6.8%患有流感.

结论:

"FluScoreVax风险评分"已成功开发并获得外部验证.
它有效地确定了很大一部分患者的流感风险较低.
该评分以应用程序的形式提供,以促进临床使用.

关键词:

临床预测规则临床预测规则基于证据的医学基于证据的医学.传染性疾病传染性疾病流感是一次流感.流感疫苗流感疫苗的使用后勤回归的逻辑回归呼吸道疾病呼吸道疾病风险评分风险评分风险评分远程医疗服务是远程医疗服务.疫苗接种疫苗接种

更多相关视频

Use of an Influenza Antigen Microarray to Measure the Breadth of Serum Antibodies Across Virus Subtypes

Use of an Influenza Antigen Microarray to Measure the Breadth of Serum Antibodies Across Virus Subtypes

Published on: July 26, 2019

A Luciferase-fluorescent Reporter Influenza Virus for Live Imaging and Quantification of Viral Infection

A Luciferase-fluorescent Reporter Influenza Virus for Live Imaging and Quantification of Viral Infection

Published on: August 14, 2019

相关概念视频

Relative Risk

Relative Risk

Relative risk (RR) is a statistical measure commonly used in epidemiology to compare the likelihood of a particular event occurring between two groups. This metric is important for evaluating the relationship between exposure to a specific risk factor and the probability of a particular outcome. It plays a crucial role in medical research, public health studies, and risk assessment. Relative risk quantifies how much more (or less) likely an event is to occur in an exposed group compared to an...

Factors Affecting the Risk of Infection

Factors Affecting the Risk of Infection

The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...

Vaccinations

Vaccinations

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...

Development of Immunocompetence

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...